Literature DB >> 7608822

The epidemiology of rotavirus infections: a global perspective.

I E Haffejee1.   

Abstract

Rotavirus, which is the most common cause of infantile diarrhea worldwide, mainly affects infants between the ages of 6 and 24 months. Most infections in human newborns are mild or asymptomatic, due to the inherently attenuated nature of the "nursery" rotavirus strains. Adults are also sometimes affected, especially those in families with an infected child; the disease also occurs in closed adult communities. HIV-infected persons, travelers, or as a result of water-borne epidemics. Nosocomially acquired hospital infections add to morbidity and to the cost of hospitalization. A winter predominance of rotavirus diarrhea has been noted in temperate climates but not in tropical areas. Group A rotavirus infections are generally more common, but human infections with groups B and C have also been documented. The prevalence of serum antibodies is high during the neonatal period, but it declines sharply between the ages of 3 and 6 months, then rises steeply, peaking at approximately 2 years and remaining high into adulthood. Vaccines against rotavirus are currently under evaluation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608822     DOI: 10.1097/00005176-199504000-00003

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  14 in total

1.  VP4 and VP7 genotyping of rotavirus samples recovered from infected children in Ireland over a 3-year period.

Authors:  J O'Mahony; B Foley; S Morgan; J G Morgan; C Hill
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  ROTASCORE Study: epidemiological observational study of acute gastroenteritis with or without rotavirus in Greek children younger than 5 years old.

Authors:  Ioannis Kavaliotis; Vassiliki Papaevangelou; Vassiliki Aggelakou; Lito Mantagou; Georgios Trimis; Vithleem Papadopoulou; Georgia Vlachaki; Nikoleta Nikolakopoulou; Andreas Konstantopoulos
Journal:  Eur J Pediatr       Date:  2007-07-25       Impact factor: 3.183

Review 3.  Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis.

Authors:  Karen Levy; Alan E Hubbard; Joseph N S Eisenberg
Journal:  Int J Epidemiol       Date:  2008-12-04       Impact factor: 7.196

4.  Shared and group-specific features of the rotavirus RNA polymerase reveal potential determinants of gene reassortment restriction.

Authors:  Sarah M McDonald; Daniel Aguayo; Fernando D Gonzalez-Nilo; John T Patton
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

5.  Survey on rotavirus infections in a German pediatric hospital.

Authors:  R Berner; R F Schumacher; J Forster
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

6.  Severe gastroenteritis associated with G3P[9] rotavirus in Taiwan.

Authors:  K-P Hwang; Y-C Huang; K Bányai; H-S Wu; F-Y Chang; D C-F Yang; C A Hsiung; J-S Lin; B Jiang; J R Gentsch; F-T Wu
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

7.  Sensitive detection of RNA viruses associated with gastroenteritis by a hanging-drop single-tube nested reverse transcription-PCR method.

Authors:  Rodney Mark Ratcliff; James Christopher Doherty; Geoffrey David Higgins
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  FIRST MOLECULAR DETECTION AND VP7 (G) GENOTYPING OF GROUP A ROTAVIRUS BY SEMI-NESTED RT-PCR FROM SEWAGE IN NIGERIA.

Authors:  Babatunde Olanrewaju Motayo; Adekunle Johnson Adeniji; Adedayo Omotayo Faneye
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

9.  Etiological agents of infectious diarrhea: implications for requests for microbial culture.

Authors:  P Rohner; D Pittet; B Pepey; T Nije-Kinge; R Auckenthaler
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 10.  Use of probiotics in children with acute diarrhea.

Authors:  Hania Szajewska; Jacek Z Mrukowicz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.